These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7509898)

  • 1. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
    Friedrichs GS; Chi L; Gralinski MR; Black SC; Basler GC; Mu DX; Pewitt SR; Johnson CR; Lucchesi BR
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):314-23. PubMed ID: 7752658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
    Black SC; Chi LG; Mu DX; Lucchesi BR
    J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
    Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction.
    Schmitt H; Cabo C; Coromilas JC; Wit AL
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):1025-33. PubMed ID: 11573692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
    Drexler AP; Micklas JM; Brooks RR
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
    Chi LG; Mu DX; Lucchesi BR
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits.
    Moschovidis V; Simopoulos V; Stravela S; Dipla K; Hatziefthimiou A; Stamatiou R; Aidonidis I
    J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):65-71. PubMed ID: 31242756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
    Venkatesh N; Lynch JJ; Uprichard AC; Kitzen JM; Singh BN; Lucchesi BR
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):703-10. PubMed ID: 1723767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
    J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death.
    Friedrichs GS; Abreu JN; Cousins GR; Chi L; Borlak J; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 1996 Oct; 1(4):313-324. PubMed ID: 10684432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.
    Todt H; Krumpl G; Zojer N; Krejcy K; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):290-7. PubMed ID: 7694159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias].
    Guo Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):119-22, 134. PubMed ID: 1473481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.
    Friedrichs GS; Abreu JN; Black SC; Chi L; Lucchesi BR
    Eur J Pharmacol; 1996 Jun; 306(1-3):99-106. PubMed ID: 8813621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death.
    Chi LG; Mu DX; Driscoll EM; Lucchesi BR
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):312-24. PubMed ID: 1697389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
    Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.